Bulletin 22-4

Nominations by Petition for AATB Council Officer Positions

AATB is seeking nominations for the eight AATB councils in the following leadership positions: Chairperson, Vice-Chairperson, and Secretary.

AATB Requests Meeting with FDA to Discuss Potential Litigation 

AATB's legal counsel sent an email to the FDA Office of Chief Counsel requesting a meeting to discuss potential litigation against the FDA regarding its reclassification of human acellular dermal matrix (hADM) allografts for post-mastectomy breast reconstruction.

AATB Partners with BCA to Support Tissue Banks in Managing Their Critical Supplies

Blood Centers of America (BCA) and the American Association of Tissue Banks (AATB) have partnered to provide value to its accredited institutional members with aggregated purchasing power and critical supply management services. 

Bulletin 22-3

CMS Pulls Back from Denying Claims Related to Birth Tissues

The Centers for Medicare & Medicaid Services have rescinded their February 23, 2022 mandate to broadly deny claims for “manipulated amniotic and/or placental tissue biologics for injections to treat illness.”

Bulletin 22-2

Letter in Response to the CMS Request for Information Related to Health and Safety Requirements for Transplant Programs, OPOs, and Other Facilities

AATB submitted the below letter in response to the Centers for Medicare and Medicaid Services (CMS) Request for Information (RFI) on Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations, and End-Stage Renal Disease Facilities.

Bulletin 22-1

Do supply continuity challenges keep you awake at night? Don't miss this Annual Meeting Session!

In the ever-evolving supply chain world, supply continuity challenges keep business leaders awake at night